AR and prostate carcinoma: For example, elucidating the androgen receptor (AR) structure and activity, along with its actions in cancer cell lines, led to rational drug design for treating prostate cancer, where drugs preventing androgen production and/or blocking AR action inhibit the growth of prostate cancer [271].